This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Kempharm Denmark A/s, Rempex Pharmaceuticals, Inc.. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: The Innovative Contributions of Andreas Pelz
Introduction
Andreas Pelz is a notable inventor based in Freistadt, Austria. He has made significant contributions to the field of chemistry, particularly in the development of processes for pharmaceutical compounds. With a total of 2 patents to his name, Pelz continues to push the boundaries of innovation in his area of expertise.
Latest Patents
Pelz's latest patents include groundbreaking work on processes for preparing arimoclomol citrate and its intermediates. This patent outlines a method for producing high purity arimoclomol citrate, which is crucial for its application in various therapeutic contexts. Additionally, he has developed an apparatus and continuous flow process for the production of boronic acid derivatives. This process is based on a Matteson boronic ester homologation, showcasing his innovative approach to chemical manufacturing.
Career Highlights
Throughout his career, Pelz has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Kempharm Denmark A/S and Rempex Pharmaceuticals, Inc. His work in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.
Collaborations
Pelz has collaborated with talented individuals in his field, including Zhe Zhang and Mark Read. These partnerships have fostered a creative environment that has led to the successful development of his patented processes.
Conclusion
Andreas Pelz exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents and collaborations highlight his commitment to advancing chemical processes for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile